Associations of lifestyle-related factors, hsa-miR-149 and hsa-miR-605 gene polymorphisms with gastrointestinal cancer risk

Molecular Carcinogenesis

Volumn 51, Issue SUPPL. 1, 2012, Pages

  Mw, Zhang ^a   Mj, Jin ^a   Yx, Yu ^a   Sc, Zhang ^a   B, Liu ^b   X, Jiang ^a   Yf, Pan ^a   Ql, Li ^c   Xy, Ma ^c   K, Chen ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Hangzhou City Center for Disease Control and Prevention   (China)

^c Institute for Cancer Prevention of Jiashan County   (China)

Author keywords

Gastrointestinal cancer; Hsa miR 149; Hsa miR 605; Polymorphism; Susceptibility

Indexed keywords

MICRORNA; MICRORNA 149; MICRORNA 605; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; GENETIC ASSOCIATION; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; IRRITABILITY; LIFESTYLE; LUNG BURN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; TEA;

AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRRITABLE MOOD; LIFE STYLE; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SMOKING; STOMACH NEOPLASMS; TEA;

EID: 84867143336     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20863     Document Type: Article

References (36)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCA. Int J Cancer 2008; 127: 2893-2917.
2. Lemmens V, Steenbergen LV, Janssen-Heijnen M, Martijn H, Rutten H, Coebergh JW. Trends in colorectal cancer in the south of the Netherlands 1975-2007: Rectal cancer survival levels with colon cancer survival. Acta Oncol; 49: 784-796.
3. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010; 116: 544-573.
4. Sung JJ, Lau JY, Goh KL, Leung WK. Increasing incidence of colorectal cancer in Asia: Implications for screening. Lancet Oncol 2005; 6: 871-876.
5. Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009; 59: 366-378.
6. Lei T, Chen WQ, Zhang SW, et al. Prevalence trend of colorectal cancer in 10 cities and counties in China from 1988 to 2002. Zhonghua Zhong Liu Za Zhi 2009; 31: 428-433.
7. Krejs GJ. Gastric cancer: Epidemiology and risk factors. Dig Dis (Basel, Switzerland) 2010; 28: 600-603.
8. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol 2006; 12: 17-20.
9. Tsoi KK, Pau CY, Wu WK, Chan FK, Griffiths S, Sung JJ. Cigarette smoking and the risk of colorectal cancer: A meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol 2009; 7: 682-688 e1-5.
10. Boehm K, Borrelli F, Ernst E, et al. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev 2009 (3): CD005004.
11. Chen PY, Meister G. microRNA-guided posttranscriptional gene regulation. Biol Chem 2005; 386: 1205-1218.
12. Xiao J, Lin H, Luo X, Luo X, Wang Z. miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress. EMBO J 2011; 30: 524-532.
13. Schaefer A, Jung M, Mollenkopf HJ, et al. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 2010; 126: 1166-1176.
14. Liu B, Zhang Y, Jin M, et al. Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk. Mol Carcinog 2010; 49: 75-84.
15. Zhang Y, Liu B, Jin M, et al. Genetic polymorphisms of transforming growth factor-beta1 and its receptors and colorectal cancer susceptibility: A population-based case-control study in China. Cancer Lett 2009; 275: 102-108.
16. Slaby O, Svoboda M, Fabian P, et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 2007; 72: 397-402.
17. Chen X, Guo X, Zhang H, et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 2009; 28: 1385-1392.
18. Ng EK, Tsang WP, Ng SS, et al. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 2009; 101: 699-706.
19. Bandres E, Agirre X, Bitarte N, et al. Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 2009; 125: 2737-2743.
20. Tie Y, Liu B, Fu H, Zheng X. Circulating miRNA and cancer diagnosis. Sci China C Life Sci 2009; 52: 1117-1122.
21. Cissell KA, Rahimi Y, Shrestha S, Hunt EA, Deo SK. Bioluminescence-based detection of microRNA, miR21 in breast cancer cells. Anal Chem 2008; 80: 2319-2325.
22. Yamamichi N, Shimomura R, Inada K, et al. Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clin Cancer Res 2009; 15: 4009-4016.
23. Gao W, Yu Y, Cao H, et al. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother 2010; 64: 399-408.
24. Xiao B, Guo J, Miao Y, et al. Detection of miR-106a in gastric carcinoma and its clinical significance. Clin Chim Acta 2009; 400: 97-102.
25. Habbe N, Koorstra JB, Mendell JT, et al. MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther 2009; 8: 340-346.
26. Wang K, Guo H, Hu H, et al. A functional variation in pre-microRNA-196a is associated with susceptibility of esophageal squamous cell carcinoma risk in Chinese Han. Biomarkers; 2010; 15: 614-618.
27. Li XD, Li ZG, Song XX, Liu CF. A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathology 2010; 42: 669-673.
28. Tian T, Shu Y, Chen J, et al. A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev 2009; 18: 1183-1187.
29. Xu B, Feng NH, Li PC, et al. A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo. Prostate 2010; 70: 467-472.
30. Sun G, Yan J, Noltner K, et al. SNPs in human miRNA genes affect biogenesis and function. RNA 2009; 15: 1640-1651.
31. Kim Y, Shin A, Gwack J, et al. Cigarette smoking and gastric cancer risk in a community-based cohort study in Korea. J Prev Med and Public Health (Yebang Uihakhoe Chi) 2007; 40: 467-474.
32. Sjodahl K, Lu Y, Nilsen TI, et al. Smoking and alcohol drinking in relation to risk of gastric cancer: A population-based, prospective cohort study. Int J Cancer 2007; 120: 128-132.
33. Xu YY, Jin HY, Tan XZ, Liu XF, Ding YJ. Tea polyphenol inhibits colorectal cancer with microsatellite instability by regulating the expressions of HES1, JAG1, MT2A and MAFA. J Chin Integr Med (Zhong Xi Yi Jie He Xue Bao) 2010; 8: 870-876.
34. Yang G, Shu XO, Li H, et al. Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol Biomarkers Prev 2007; 16: 1219-1223.
35. Inoue M, Sasazuki S, Wakai K, et al. Green tea consumption and gastric cancer in Japanese: A pooled analysis of six cohort studies. Gut 2009; 58: 1323-1332.
36. Chen MJ, Chiou YY, Wu DC, Wu SL. Lifestyle habits and gastric cancer in a hospital-based case-control study in Taiwan. Am J Gastroenterol 2000; 95: 3242-3249.